| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |